Oculus has introduced “Meibo Analytics,” a new artificial intelligence (AI)-assisted decision-support tool for the Keratograph 5M designed to help clinicians evaluate meibomian gland dysfunction (MGD).

The software uses AI-driven image analysis to quantify meibography images and support clinicians in interpreting structural changes in the meibomian glands.

According to Oculus, unlike functional tests alone, meibography provides structural insights into gland health that can help clinicians identify disease progression. However, interpreting these images can be subjective, particularly in the early and intermediate stages of MGD.

Meibo Analytics was developed to address those inconsistencies by applying AI-based structure analysis to meibography images, according to the company. Integrated into the company’s JENVIS Pro Dry Eye Report, the tool is designed to evaluate gland morphology according to the Arita grading scale, assessing gland dropout, and overall gland structure.